Pediatric and Adolescent Nephrology Facing the Future: Diagnostic Advances and Prognostic Biomarkers in Everyday Practice

doi:10.3390/books978-3-0365-5974-2

Reprint

Download Flyer

Pediatric and Adolescent Nephrology Facing the Future: Diagnostic Advances and Prognostic Biomarkers in Everyday Practice

Edited by

December 2022

304 pages

ISBN978-3-0365-5973-5 (Hardback)
ISBN978-3-0365-5974-2 (PDF)

https://doi.org/10.3390/books978-3-0365-5974-2

Free download (PDF)

This book is a reprint of the Special Issue Pediatric and Adolescent Nephrology Facing the Future: Diagnostic Advances and Prognostic Biomarkers in Everyday Practice that was published in

Medicine & Pharmacology

Public Health & Healthcare

Summary

The Special Issue entitled “Pediatric and adolescent nephrology facing the future: diagnostic advances and prognostic biomarkers in everyday practice” contains articles written in the era when COVID-19 had not yet been a major clinical problem in children. Now that we know its multifaceted clinical course, complications concerning the kidneys, and childhood-specific post-COVID pediatric inflammatory multisystem syndrome (PIMS), the value of diagnostic and prognostic biomarkers in the pediatric area should be appreciated, and their importance ought to increase.

Format

Hardback

License

Keywords

chronic kidney disease; cytokines; solitary functioning kidney; tumor necrosis factor-like weak inducer of apoptosis; netrin-1; renal tubular damage; premature newborns; overactive bladder; urinary microbiome; children; adolescents; children; chronic kidney disease; cystatin C; galectin-3; solitary functioning kidney; periostin; primary hypertension; children; adolescents; arterial damage; blood pressure; neurogenic bladder; myelomeningocele; markers; furosemide stress test; hyperfiltration; [IGFBP-7] × [TIMP-2]; NGAL; renal angina index; renal functional reserve; tubular damage; tubuloglomerular feedback; neurotrophins; transcutaneous electrical nerve stimulation; overactive bladder; hemopexin; nephrotic syndrome; children; HNF1B; hyperuricemia; PTH; renal function; uric acid; FEUA; sclerostin; primary hypertension; children; adolescents; arterial damage; blood pressure; obesity; childhood; dental caries; gingivitis; kidney injury; glomerulopathy; uric acid; cystatin C; obesity; glomerular injury; alpha-1 acid glycoprotein; urinary mRNA expression of podocyte-associated proteins; cathepsin B; tubular damage; premature neonates; immaturity; chronic kidney disease; NT-proBNP; children; cardiovascular disease; common carotid artery intima-media thickness; bone morphogenetic protein (BMP)-2; bone morphogenetic protein (BMP)-6; extracellular matrix metalloproteinases inducer (EMMPRIN); macrophage migration inhibitory factor (MIF); tubular functional reserve; tubular damage; periostin; cytokeratin-18; endoglin; transforming growth factor-β1; renal fibrosis; congenital obstructive nephropathy; children; diabetic kidney disease; vascular endothelial markers; children; eGFR; adenine nucleotide metabolites; chronic renal failure; children; antibiotic resistance; Escherichia coli; inflammatory markers; urinary tract infection; B2M; cancer; CCS; children; CKD; chronic kidney disease; nephropathies; renal toxicity; voiding cystography; infection; urinary tract; IgA nephropathy; IgA vasculitis with nephritis; vanin-1; periostin; biomarker; children; urinary tract infections; artificial intelligence; machine learning; medical decision support system; n/a